Breakout Stocks: How to trade Vijaya Diagnostic & Navin Fluorine on Friday?

Indian market closed lower on Thursday tracking muted global cues. The BSE Sensex fell more than 500 points while the Nifty50 managed to hold above 23,500 levels.

Sectorally, buying was seen in FMCG while selling was visible in power, energy, oil & gas and realty stocks.

Stocks that hit fresh highs include names like Vijaya Diagnostic Center which rose over 1%, and Navin Fluorine closed with gains of over 9% on Thursday.

We spoke to an analyst on how one should look at these stocks the next trading day entirely from an educational point of view:

Analyst: Hariprasad Kizhakkethara, SEBI Registered RA (INH200009351), Director of Livelong Wealth.

Navin Fluorine International: Hold

Navin Fluorine International Ltd is primarily engaged in producing refrigeration gases, inorganic fluorides, specialty organofluorines and offers contract research and manufacturing services.

• The stock is currently Consolidating between 3824.55 and 3,333 levels and This stock has a high probability of retesting to 4,535 Rs and 4,999 Levels.
• Considering its Technical and Fundamentals, it’s on a HOLD Rating and can be on Watchlist for a Good Long-Term Investment.

Vijaya Diagnostic Centre Ltd: "Buy on Dip"

Vijaya Diagnostics is a leading diagnostic service provider in India, offering a wide range of pathology and radiology tests. Known for its strong financials and efficient management, it combines advanced technology with skilled professionals to deliver reliable results.

• The weekly price chart of Vijaya Diagnostic Center Ltd highlights a bullish breakout from a well-defined ascending channel pattern, indicating strong momentum.

• Recommendation: "Buy on Dip" for long- term investment.

• The breakout from the ascending channel suggests robust technical strength and potential for further upside.

• This stock is positioned as a promising long- term investment opportunity, supported by bullish technical indicators.

(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)